Skip to main content

Table 1 Characteristics of the patients with different stages of renal disease (CKD chronic kidney disease; ESRD-HD end-stage renal disease treated with hemodialysis; renal transplant: recipients of a renal transplant)

From: High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy – an observational cross-sectional study

 

CKD

N = 112

ESRD-HD

N = 24

Renal transplant

N = 72

P (ANOVA) Kruskal Wallis test

Age

66 (51, 76)

63 (50, 76)

60 (49, 67)

0.04

Sex (m/f)

79/33 (71%/29%)

17/7 (71%/29%)

51/21 (71%/29%)

0.999

Body mass index (kg/m2)

27.4 (23.9, 31.0)

24.7 (21.8, 27.5)

26.0 (24.0, 29.3)

0.02

Hypertension n (%)

82 (92%)

23 (96%)

28 (39%)

< 0.001

Diabetes mellitus n (%)

33 (30%)

11 (46%)

11 (15%)

< 0.001

Current smoking n (%)

17 (15%)

3 (12%)

8 (11%)

0.104

No. of prescribed medicationa

7 (4, 9)

14 (12, 17)

9 (7, 11)

< 0.001

eGFRb (ml/min/1.73m2)

28 (18, 38)

6 (5, 8)

53 (38, 73)

< 0.001

CKD stages n (1–3/4/5)

44/52/16

0/0/24

59/11/1

 

Systolic blood pressure (mmHg)

134 (125, 145)

159 (142, 175)c

130 (120, 140)

< 0.001

Diastolic blood pressure (mmHg)

80 (70, 82)

67 (61, 77)c

80 (71, 82)

< 0.001

Years on dialysis

2 (1–4)

 

Years since renal transplant

8.9 (5.9, 15.5)

 

Serum creatinine (μmol/L)

209 (159, 278)

656 (560, 844)

114 (96, 164)

< 0.001

Serum urea (mmol/L)

16 (11.2, 20.0)

23 (19, 28)

9.3 (6.7, 13.8)

< 0.001

Hemoglobin (g/L)

12.9 ± 1.6

11.9 ± 1.6

13.6 ± 1.9

< 0.001

Serum albumin (g/L)

44 (41, 45)

40.5 (38, 43)

43 (41, 45)

0.001

Serum C-reactive protein (mg/L)

3 (1, 6)

3 (1, 16)

2 (1, 4)

0.08

HbA1c (%)

5.8 (5.5, 6.3)

5.8 ± 1.2

5.7 (5.5, 6.1)

0.12

Urinary albumin (mg/mmol Crea)

30 (5, 104)

2.7 (0.9, 17.0)

< 0.001

  1. aMedication and supplements described in The Norwegian Pharmaceutical Product Compendium (Felleskatalogen AS)
  2. beGFR was calculated using CKD-Epi equation [18]
  3. cpre dialysis, median (IQR)